Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Kevin L. Farmer"'
Autor:
Michael Joseph Urban, Rick T. Dobrowsky, Pan Pan, Brian S. J. Blagg, Jiacheng Ma, Huiping Zhao, Kevin L. Farmer
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 348:281-292
Impaired neuronal mitochondrial bioenergetics contributes to the pathophysiologic progression of diabetic peripheral neuropathy (DPN) and may be a focal point for disease management. We have demonstrated that modulating heat shock protein (Hsp) 90 an
Autor:
Neena K. Sharma, Rupali Singh, Patricia M. Kluding, Jason Rucker, Kevin L. Farmer, Stephen Jernigan, Mamatha Pasnoor, Douglas E. Wright
Publikováno v:
Journal of Diabetes and its Complications. 26:424-429
Although exercise can significantly reduce the prevalence and severity of diabetic complications, no studies have evaluated the impact of exercise on nerve function in people with diagnosed diabetic peripheral neuropathy (DPN). The purpose of this pi
Publikováno v:
Pharmacological Reviews. 64:880-900
Diabetic peripheral neuropathy (DPN) is a common complication of diabetes that is associated with axonal atrophy, demyelination, blunted regenerative potential, and loss of peripheral nerve fibers. The development and progression of DPN is due in lar
Autor:
S. Janette Williams, Karthik Ramachandran, Lesya Novikova, Rick T. Dobrowsky, Lisa Stehno-Bittel, Sonia Rawal, Brian S. J. Blagg, Kevin L. Farmer
Publikováno v:
Experimental Diabetes Research
Experimental Diabetes Research, Vol 2012 (2012)
Experimental Diabetes Research, Vol 2012 (2012)
KU-32 is a novel, novobiocin-based Hsp90 inhibitor that protects against neuronal glucotoxicity and reverses multiple clinical indices of diabetic peripheral neuropathy in a rodent model. However, any drug with potential for treating diabetic complic
Autor:
Rick T. Dobrowsky, Michael Joseph Urban, Pan Pan, Kevin L. Farmer, Brian S. J. Blagg, Huiping Zhao
Quantification of intra-epidermal nerve fibers (iENFs) is an important approach to stage diabetic peripheral neuropathy (DPN) and is a promising clinical endpoint for identifying beneficial therapeutics. Mechanistically, diabetes decreases neuronal m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::788a2e472d22d2147c348582801c6af8
https://europepmc.org/articles/PMC3336191/
https://europepmc.org/articles/PMC3336191/
Publikováno v:
Medicine & Science in Sports & Exercise. 38:S396-S397
Publikováno v:
Medicine & Science in Sports & Exercise. 39:S158
Publikováno v:
Medicine & Science in Sports & Exercise. 38:S397